Prenatal Cannabis Use and Maternal Pregnancy Outcomes

Young-Wolff KC, Adams SR, Alexeeff SE, et al. Prenatal Cannabis Use and Maternal Pregnancy Outcomes. JAMA Intern Med. Published online July 22, 2024. doi:10.1001/jamainternmed.2024.3270 Key Points Question  Is prenatal cannabis

Development and Validation of the Maternal Drinking Motives Scale (M-DMS)

Paul Christiansen, Sally Hunt, Andrew Jones & Abigail K. Rose (10 Jul 2024): Development and Validation of the Maternal Drinking Motives Scale (M-DMS), Substance Use

Cannabis Use During Pregnancy

Introduction Marijuana is the most commonly used drug of abuse during pregnancy in the United States,1 with self-reported use ranging from 2–5% for all women and

Healthcare experiences of pregnant and postnatal women and healthcare professionals when facing child protection in the perinatal period: A systematic review and Critical Interpretative Synthesis

Backer KD, Rayment-Jones H, Lever Taylor B, Bicknell-Morel T, Montgomery E, Sandall J, et al. (2024) Healthcare experiences of pregnant and postnatal women and healthcare

Independent and Interactive Impacts of Prenatal Exposure to Legal Substances and Childhood Trauma on Emotion Processing in Pre-adolescents: Preliminary Findings From the ABCD Study

Lepow L, Wagner A, Peri S, Adams F, Ramakrishnan SA, Alam MA, Shaik RB, Hubbard NA, Koenigsberg HW, Hurd Y, Tapert SF, Ivanov I, Parvaz

The most common teratogens as factors of mutability: A literature review

ABSTRACTIntroduction: the teratogenic agents during the embryonic period can result in disorders in organ differentiation. Concerns regarding medication use during pregnancy heightened after the thalidomide

1 18 19 20 21 22 136